when fda approve compass pathways' comp360 psilocybin
Before October 2027
when fda approve compass pathways' comp360 psilocybin. Best Yes near 83¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 83¢ · Best No: 23¢ · 1 platform
- Kalshi: Yes 83¢ / No 23¢
LIVE
Before October 2027
Volume
$2.1K
$62 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Oct 1, 2027
~472 days left
Category
Culture
Yes
83¢
Kalshi
No
23¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Oct 1, 2027
Time Left472 days
Status● Active
CategoryCulture
Yes
83¢
Kalshi
Payout 1.2x
No
23¢
Kalshi
Payout 4.3x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In